MARY ANNE ROBINSON: Open Payments
NPI 1508001397 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 74 payments from 15 companies in 2025. Trend: 2023 $1,515 · 2024 $2,089 · 2025 $1,601
Food & beverage: $1,536Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $345 |
| GENZYME CORPORATION | 8 | $225 |
| Novartis Pharmaceuticals Corporation | 9 | $215 |
| Janssen Biotech, Inc. | 4 | $155 |
| UCB, Inc. | 4 | $123 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $90 |
| PFIZER INC. | 4 | $87 |
| Lilly USA, LLC | 4 | $74 |
| Amgen Inc. | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Bimzelx, COSENTYX, RINVOQ, ILUMYA, CIBINQO.
Industry payments across MD — which companies pay providers there.
